Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirsh

Showing results (51-60 of 2,959) with videos related to

Pageof 296
Sort By:
Physician'S Management|September 7, 1987
The five hottest issues in malpracticeH Hirsh
Seminars in Hematology|July 13, 2001
Developing a novel antithrombotic in the academic environmentJ Hirsh
Annals of Internal Medicine|August 1, 1992
Subcutaneous compared with intravenous heparin for deep vein thrombosisJ Hirsh
Circulation|October 1, 1992
Oral anticoagulant therapy. Urgent need for standardizationJ Hirsh
Australasian Annals of Medicine|January 1, 1970
Dosage regimens for streptokinase treatment: evaluation of a standard dosage scheduleJ Hirsh
L'Union Medicale Du Canada|February 1, 1978
[Diagnosis of venous thrombo--emboli]J Hirsh
Progress in Clinical and Biological Research|January 1, 1984
Central nervous system pharmacology of the dietary methylxanthinesK Hirsh
Physiology & Behavior|November 1, 1970
Lack of variability or perseveration: describing the effect of hippocampal ablationR Hirsh
Thrombosis Research|February 10, 2026
In memory of Dr. Jeffrey GinsbergJack Hirsh
Frontiers in Oncology|July 30, 2014
Is the Evaluation of Quality of Life in NSCLC Trials Important? Are the Results to be Trusted?Vera Hirsh
Pageof 296

Showing results (51-60 of 2,959) with videos related to

Sort By:
Pageof 296
Physician'S Management|September 7, 1987
The five hottest issues in malpracticeH Hirsh
Seminars in Hematology|July 13, 2001
Developing a novel antithrombotic in the academic environmentJ Hirsh
Annals of Internal Medicine|August 1, 1992
Subcutaneous compared with intravenous heparin for deep vein thrombosisJ Hirsh
Circulation|October 1, 1992
Oral anticoagulant therapy. Urgent need for standardizationJ Hirsh
Australasian Annals of Medicine|January 1, 1970
Dosage regimens for streptokinase treatment: evaluation of a standard dosage scheduleJ Hirsh
L'Union Medicale Du Canada|February 1, 1978
[Diagnosis of venous thrombo--emboli]J Hirsh
Progress in Clinical and Biological Research|January 1, 1984
Central nervous system pharmacology of the dietary methylxanthinesK Hirsh
Physiology & Behavior|November 1, 1970
Lack of variability or perseveration: describing the effect of hippocampal ablationR Hirsh
Thrombosis Research|February 10, 2026
In memory of Dr. Jeffrey GinsbergJack Hirsh
Frontiers in Oncology|July 30, 2014
Is the Evaluation of Quality of Life in NSCLC Trials Important? Are the Results to be Trusted?Vera Hirsh
Pageof 296